维普期刊资源整合服务平台（V6.5）

30篇 您的检索式：作者名="Bauer KS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A phase Ⅰ and pharmacologic study of idarubicin cytarabine, etoposide, and the multidrug resistandc protein (MDR1/) inhibitor PSC-833 in patients with refractory leukemia显示文摘	Bauer KS Karp JE Garimella TS	2005	Leuk Res2005，29，3：	1
2	Carboxyamido-tri- azole inhibits angiogenesis by blocking the calcium-medi- ated nitric-oxide synthase-vascular endothelial growth fac- tor pathway显示文摘	Bauer KS Cude KJ Dixon SC	2000	J Pharmacol Exp Ther2000，292，1：	1
3	Vertebral fractures: clinical importance and management显示文摘	Kendler DL Bauer DC Davison KS	2016	Am J Med2016，129，2：	1
4	Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species- dependent显示文摘	Bauer KS Dixon SC Figg WD	1998	Binchem Pharmacol1998，55，11：	1
5	Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent显示文摘	Bauer KS Dixon SC Figg WD	1998	Biochemical Pharmacology1998，55，11：	1
6	Inhibition of angiogenesis by thalidomide requires metabolic activation which is species-dependent显示文摘	Bauer KS Dixon SC Figg WD	1998	Biochem Pharmacol1998，55，11：	1
7	Inhibition of angiogenesis by thalidomide requires metabolic activation,which is species dependent显示文摘	Dixon SC Figg WD	1998	Biochem Pharmacol1998，55，：	1
8	A pharmacokinetically guided phase Ⅱ study of carboxyamido-triazole in androgen-independent prostate cancer显示文摘	Bauer KS Figg WID Hamilton JM	1999	Clin Cancer Res1999，5，9：	1
9	Inhibition of angiogenesis by thalidomide requires metabolic activation which is species-dependent 显示文摘	Bauer KS Dixon SC Figg WD	1998	Biochem Pharmacol1998，55，11：	1
10	Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters显示文摘	Bauer KS Kohn EC Lush RM	1998	J Pharmacokinet Biopharm1998，26，6：	1
11	Mechanisms of suicidal erythrocyte death显示文摘	Lang KS Lang PA Bauer C	2005	Cell Physiol Biochem2005，15，5：	1
12	Mechanisms of suicidal erythrocyte death显示文摘	Lang KS Lang PA Bauer C	2005	Cell Physiol Biochem2005，15，5：	1
13	Inhibition of Angiogenesis by thalidomide requires metabolic activition, which is species-dependent显示文摘	Bauer KS Dixon SC and Figg WD	1998	Biochemical Pharmacology1998，55，11：	1
14	Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells显示文摘	Dixon SC Kruger EA Bauer KS		0，，：	1
15	Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway 显示文摘	Bauer KS Cude K J Dixon SC	2000	J Pharmacol Exp Ther2000，292，1：	1
16	Pharmacokinetics of thalidomide in an elderly prostate cancer population显示文摘	Figg WD Raje S Bauer KS		0，，：	1
17	Inhibitor of angiogenesis by thalidomide requires metabolic activativation, which is species-dependent显示文摘	Dixon SC FiggWD etal	1998	Biochem Pharmacol1998，55，11：	1
18	Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells显示文摘	Dixon SC Kruger EA Bauer KS	1999	Cancer Chemother Pharmacol1999，43，：	1
19	Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent显示文摘	Bauer KS Dixon SC Fiqq WD	1998	Biochem Pharmacol1998，55，11：	1
20	Mechanisms of suici- dal erythrocyte death显示文摘	Lang KS Lang PA Bauer C	2005	Cell Physiol Biochem2005，15，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示